Early-Onset Rectal Adenocarcinoma as the Initial Manifestation of Li- Fraumeni Syndrome Associated with a Germline TP53 p.R337H Variant: A Case Report and Literature Review

Cancer often feels like a random storm, striking without warning and seemingly without pattern. Yet, for some families, the threat is not random at all; it is written into their very biology. This is the reality of hereditary cancer syndromes, conditions where a single broken instruction in a person's genetic code makes them far more likely to develop tumors at a young age. The most famous of these is Li-Fraumeni syndrome, a rare disorder passed down from parent to child. It is caused by a flaw in a gene called TP53, which acts as the body's master security guard. Normally, this guard patrols the cells, checking for damage and ordering repairs or, if the damage is too severe, telling the cell to destroy itself to prevent it from becoming cancer. When this guard is broken, cells with damaged DNA can survive and multiply, leading to a wide variety of cancers, often appearing in children or young adults. While this syndrome is known for causing bone cancers, brain tumors, and breast cancer, doctors have long debated whether it also increases the risk for cancers of the colon and rectum, the most common types of colorectal cancer.

In a recent case report, a team of researchers from Iran and the Netherlands documented a striking example of how this syndrome can reveal itself in an unexpected way. They followed a 34-year-old man who arrived at a hospital complaining of blood in his stool, pain when passing stool, and a sudden, unexplained loss of weight. At first, the doctors treated him for what appeared to be a standard case of rectal cancer. A colonoscopy confirmed a large, aggressive tumor in his rectum, and a biopsy showed it was a poorly differentiated adenocarcinoma, a type of cancer that grows quickly and spreads easily. Despite the severity of the diagnosis, the patient initially refused further treatment. Five months later, he returned, much worse for wear, with the cancer having spread to his liver. He underwent chemotherapy and radiation, followed by a major surgery to remove the rectum, but the disease had already taken hold. He passed away nine months after his initial diagnosis.

It was only after the patient's death that the full picture of his family's history emerged, revealing a pattern that pointed to a deeper cause. The researchers learned that his mother had suffered from a brain tumor and a rare uterine cancer, while other relatives had faced gastric cancer and sarcomas. This cluster of different cancers across three generations is the hallmark of Li-Fraumeni syndrome. To confirm this suspicion, the team performed a deep genetic scan of the patient's DNA. They found a specific, broken instruction in the TP53 gene, a change known as the p.R337H variant. This specific flaw had been seen before in other populations, but finding it in an Iranian family was a new discovery. When they tested the patient's mother, sister, and niece, they found the same broken gene in all of them, confirming that the family carried the syndrome.

The significance of this case lies in what the patient's first cancer was. While Li-Fraumeni syndrome is famous for causing soft tissue sarcomas and breast cancer, this man's first and only sign of the disease was a cancer of the rectum. This is rare. In the general population, colorectal cancer is typically a disease of older age, with most patients being diagnosed after they turn 70. In this family, the cancer appeared in a man in his early thirties. The researchers reviewed dozens of other published cases to see how often this happens, and they found that while colorectal cancer can occur in people with Li-Fraumeni syndrome, it is usually not the very first sign that leads to a diagnosis. This case suggests that for young patients with colorectal cancer, especially those with a family history of diverse cancers, doctors should consider testing for Li-Fraumeni syndrome much earlier than they might otherwise.

The study also highlighted a unique aspect of the genetic flaw found in this family. The specific mutation, p.R337H, is known to behave differently depending on the person's sex and the environment, with some studies suggesting it might be more dangerous for women than men. In this family, the mother carried the gene and developed cancer, as did the son, but the pattern of illness varied. The researchers noted that the mother's brain tumor was a meningioma, a type of tumor that is not typically associated with Li-Fraumeni syndrome, suggesting that this specific genetic variant might cause a wider range of tumors than previously thought. This finding adds a new layer of complexity to how doctors monitor families with this syndrome, implying that surveillance might need to include a broader range of organs than just the ones traditionally watched.

Ultimately, this report serves as a reminder that cancer can wear many masks. The patient's story began with a common symptom—bleeding from the rectum—but the root cause was a rare, inherited genetic condition that had been hiding in his family for generations. By identifying the specific genetic error, the researchers were able to warn the remaining family members that they, too, carry the same risk. This allows them to undergo careful, lifelong screening to catch any new cancers at the earliest possible moment, potentially saving lives that would otherwise be lost. The case underscores a vital lesson for modern medicine: when a young person develops a serious cancer, looking beyond the immediate tumor to the family tree and the genetic code can reveal the true nature of the threat.